Related Experiment Video
Updated: Jun 5, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Recent advances in management of cryptococcal meningitis: commentary
Tania C Sorrell1, Sharon C-A Chen
1Centre for Infectious Diseases and Microbiology and the University of Sydney at Westmead Hospital Darcy Road, Westmead, NSW 2145 Australia.
Cryptococcal meningitis requires prompt antifungal treatment, including amphotericin B and flucytosine induction therapy, followed by fluconazole maintenance. Management also involves controlling intracranial pressure and addressing complications like cryptococcomas.
Area of Science:
- Infectious Diseases
- Mycology
- Neurology
Background:
- Cryptococcal meningitis poses a significant global health challenge, causing high morbidity, especially in resource-limited settings.
- Treatment strategies are individualized based on patient factors, disease severity, and the specific *Cryptococcus* species involved.
Purpose of the Study:
- To outline current best practices for managing cryptococcal meningitis.
- To emphasize the importance of specific antifungal regimens and supportive care measures.
Main Methods:
- Review of recent clinical studies and established guidelines for cryptococcal meningitis treatment.
- Analysis of factors influencing treatment decisions, including host immunity, disease severity, and fungal species.
Main Results:
- Rapidly fungicidal induction therapy with amphotericin B and flucytosine is recommended for optimal outcomes.
- Maintenance therapy with fluconazole is crucial until immune reconstitution.
- *Cryptococcus gattii* meningitis necessitates extended induction and eradication therapy.
Conclusions:
- Effective management requires prompt initiation of appropriate antifungal regimens and vigilant monitoring for complications.
- Control of intracranial pressure, hydrocephalus, and management of cryptococcomas are essential.
- Clinicians must be aware of immune restoration inflammatory syndrome (IRIS) and consider adjuvant therapies when needed.
Related Concept Videos
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Endocarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Brain Abscess l: Introduction